BGMS (Bio Green Med Solution Inc) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Bio Green Med Solution Inc (BGMS)

The daily price chart for Bio Green Med Solution Inc (BGMS) reflects the dynamics of a company whose research centers and inhibitor synthesis production lines are operating at full capacity, eliminating any downtime. The current metric stands at 0.88. The financial model is based on developing agents to control the division of tumor cells in leukemia. Stable profits are secured by patents and consistent patient demand for targeted therapy methods.

Cyclacel (BGMS): Rasio Kapitalisasi marang Nilai Buku saka 13.09.2025 nganti 28.10.2026
Produk merek Cyclacel Pharmaceuticals

Searching for sustainable assets requires analyzing the gap between market expectations and tangible assets. This indicator compares the current market value of the business with its net tangible assets, revealing the extent to which the company is overvalued or undervalued. For Bio Green Med Solution Inc. (BGMS), this reflects the market's willingness to award a premium for scientific authority in the development of targeted inhibitors. A decline in the company's price-to-book ratio may signal a loss of confidence in its innovations. Analyze the trend on this chart to determine the entry point.